Halberd Corporation

Halberd Corporation

Share · US4053311092 (OTC)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Halberd Corporation
No Price
Closing Price OTC 27.04.2026: 0,001 USD
27.04.2026 18:44
Current Prices from Halberd Corporation
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
HALB
USD
27.04.2026 18:44
0,001 USD
0,00005 USD
+4,76 %
Company Profile for Halberd Corporation Share
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Company Data

Name Halberd Corporation
Company Halberd Corporation
Website https://halberdcorporation.com
Primary Exchange OTC UTC
ISIN US4053311092
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO William A. Hartman
Country United States of America
Currency USD
Employees -
Address PO Box 25, 16133 Jackson Center
IPO Date 2012-09-25

Ticker Symbols

Name Symbol
Over The Counter HALB
More Shares
Investors who hold Halberd Corporation also have the following shares in their portfolio:
AES Andes S.A.
AES Andes S.A. Share
USA 20/30
USA 20/30 Bond